Mezent tablets 2mg

Mezent tablets 2mg (Siponimod fumaric acid), manufactured by Novartis Pharma (YJ code: 3999051F2020, standard: 2mg 1 tablet), is a selective sphingosine-1-phosphate receptor modulator. It is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including active secondary progressive MS, by reducing inflammation in the central nervous system.